Genentech
This role involves developing and executing Genentech/Roche’s Foundational Data and Models strategy in Computational Neuroscience to deliver new treatments for neurodegenerative and neuroinflammatory diseases. The position focuses on leveraging AI, data ecosystems, and advanced computational methods to accelerate the Neuroscience portfolio and support pipeline programs. It requires a scientist with deep expertise in biological pathways and computational analysis to drive impactful research and target validation.
Headquarters
South San Francisco, California, United States
Company Size
10001+ employees
Founded
1976
Genentech is a research-driven biotechnology company that develops medicines through breakthrough science to treat people with serious and life‑threatening diseases. It discovers, advances and manufactures biologic therapies — including monoclonal antibodies and targeted medicines — across oncology, immunology, neuroscience and other therapeutic areas, moving candidates through discovery and clinical trials. Founded in 1976 and now part of the Roche group, Genentech is known for its patient-centered focus and for translating deep science into transformative, widely used medicines.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Genentech.
Principal Scientist, Computational Biology
Bristol Myers Squibb
Principal Scientist Computational Biology
Bristol Myers Squibb
Scientist II
WuXi AppTec
Associate Director, Tumor Functional Genomics and Perturbation Analytics
BioLife Plasma Services
Postdoctoral Fellowship in Computational Neuroscience and Multimodal AI
The University of British Columbia
Scientist
Arc Institute